Abstract:Phasing of heterozygous alleles is critical for interpretation of cis -effects of disease-relevant variation. For population studies, phase is often inferred from external data but read-based phasing approaches that span long genomic distances would be more accurate because they enable both genotype and phase to be obtained from a single dataset. To demonstrate how read-based phasing can provide functional insights, we sequenced 477 individuals with Cystic Fibrosis (CF) using linked-read sequencing. We benchmark read-based phasing with different short- and long-read sequencing technologies, prioritize linked-read technology as the most informative and produce a benchmark phase call set from reference sample HG002 for the community. The 477 samples display an average phase block N50 of 4.39 Mb. We use these samples to construct a graph representation of CFTR haplotypes, which facilitates understanding of complex CF alleles. Fine-mapping and phasing of the chr7q35 trypsinogen locus associated with CF meconium ileus demonstrates a 20 kb deletion and a PRSS2 missense variant p.Thr8Ile (rs62473563) independently contribute to meconium ileus risk (p=0.0028, p=0.011, respectively) and are PRSS2 pancreas eQTLs (p=9.5e-7 and p=1.4e-4, respectively), explaining the mechanism by which these polymorphisms contribute to CF. Phase enables access to haplotypes that can be used for genome graph or reference panel construction, identification of cis -effects, and for understanding disease associated loci. The phase information from linked-reads provides a causal explanation for variation at a CF-relevant locus which also has implications for the genetic basis of non-CF pancreatitis to which this locus has been reported to contribute. ### Competing Interest Statement DMC received an honorarium for teaching module development for Vertex Pharmaceuticals. NM is doing contract research trials for Vertex Phaemaceuticals and Abbvie. ALS has received speaking fees for educational programs sponsored by Vertex Pharmaceuticals. BSQ has received speaker fees from Vertex Pharmaceuticals and has served as site PI for several Vertex-sponsored clinical trials. WML is a study investigator for Vertex Pharmaceuticals. ET and FR act as consultants for Vertex Pharmaceuticals. MS participated in Vertex clinical trials and received payment for education modules. SM, AC, JG, FL, BT, WWLS, JW, ZW, RVP, KK, AH, NP, JA, CW, GCM, SB, DA, EB, CB, MC, AP, MP, RVW, DH, MJS, ET, PW, LS, FR, and LJS have no conflicts of interest. * CF : cystic fibrosis CFTR : cystic fibrosis transmembrane conductance WGS : whole genome sequencing GWAS : genome-wide association studies MI : meconium ileus LD : linkage disequilibrium PacBio : Pacific Biosciences 10XG : 10x Genomics CGMS : Canadian CF Gene Modifier Study Consortium CLR : PacBio continuous long-reads CCS : PacBio circular consensus sequence VCF : variant call format GIAB : Genome in a Bottle HMW : high molecular weight TCAG : The Centre for Applied Genomics GTEx : Genotype-Tissue Expression ER : endoplasmic reticulum SRP : signal recognition particle QC : quality control

Targeted phasing of 2–200 kilobase DNA fragments with a short-read sequencer and a single-tube linked-read library method

Ultra-low input single tube linked-read library method enables short-read NGS systems to generate highly accurate and economical long-range sequencing information for de novo genome assembly and haplotype phasing

Ultralow-input single-tube linked-read library method enables short-read second-generation sequencing systems to routinely generate highly accurate and economical long-range sequencing information

Ultra-low input single tube linked read library method enables NGS systems generate accurate & economical long read information for broad applications.

A Novel Approach to Detect Large Indels from Targeted Sequencing Data in Clinical Cancer Setting

Efficient whole genome haplotyping and high-throughput single molecule phasing with barcode-linked reads

High-throughput method for the hybridisation-based targeted enrichment of long genomic fragments for PacBio third-generation sequencing

Targeted Isolation of Cloned Genomic Regions by Recombineering for Haplotype Phasing and Isogenic Targeting.

Simultaneous de novo calling and phasing of genetic variants at chromosome-scale using NanoStrand-seq

Preparing a re-sequencing DNA library of 2 cancer candidate genes using the ligation-by-amplification protocol by two PCR reactions

A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.

Targeted genome fragmentation with CRISPR/Cas9 enables fast and efficient enrichment of small genomic regions and ultra-accurate sequencing with low DNA input (CRISPR-DS)

A long-read sequencing strategy with overlapping linkers on adjacent fragments (OLAF-Seq) for targeted resequencing and enrichment

High Quality Phasing Using Linked-Read Whole Genome Sequencing of Patient Cohorts Informs Genetic Understanding of Complex Traits

Rapid and highly-specific generation of targeted DNA sequencing libraries enabled by linking capture probes with universal primers

Long-read sequencing for fast and robust identification of correct genome-edited alleles: PCR-based and Cas9 capture methods

Long range haplotyping of paired-homologous chromosomes by single-chromosome sequencing of a single cell

Genotyping single nucleotide polymorphisms in homologous regions using multiplex kb level amplicon capture sequencing

Accurate whole-genome sequencing and haplotyping from 10 to 20 human cells

ClinPharmSeq: A targeted sequencing panel for clinical pharmacogenetics implementation

HiPhase: jointly phasing small, structural, and tandem repeat variants from HiFi sequencing